Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer

Anastasia Malek1, Reinhold Schäfer, Oleg Tchernitsa

  • 1Institute of Pathology, Charité Universitätsmedizin Berlin, Germany.

Cancer Treatment Reviews
|December 1, 2009
PubMed

Insights

Researchers reviewed gene expression profiling and conventional methods to find ovarian cancer therapeutic targets. This summary focuses on promising targets for cancer cell interference, their biological roles, and therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer initiation and progression involve complex genetic alterations.
  • Gene expression profiling and conventional methods have identified numerous potential therapeutic targets.
  • Targeted therapies offer promise for specific interference in cancer cells.

Purpose of the Study:

  • To review and summarize promising therapeutic targets for ovarian cancer.
  • To categorize identified targets based on subcellular localization and biological processes.
  • To discuss the impact of these targets on experimental, pre-clinical, and clinical therapy.

Main Methods:

  • Literature review of gene expression profiling studies.
  • Analysis of conventional gene identification approaches.
  • Categorization of therapeutic targets by subcellular localization and biological function.
  • Evaluation of therapeutic impact across different stages of research and treatment.

Main Results:

  • Identification of a plethora of potential therapeutic targets for ovarian cancer.
  • Grouping of targets based on their subcellular localization and involvement in key biological processes.
  • Discussion of the therapeutic potential and impact of these targets in various research and clinical settings.

Conclusions:

  • Numerous promising therapeutic targets for ovarian cancer have been identified.
  • Understanding target localization and function is crucial for developing effective therapies.
  • These targets hold significant potential for advancing ovarian cancer treatment strategies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...